Leerink Partners
17
70M
16
0.59
1
0.06
12
- Areas of investment
Summary
Leerink Partners is the famous Corporate Investor, which was founded in 1995. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Boston.
The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight TESARO, AlloVir, Living Proof. We can highlight the next thriving fund investment areas, such as Medical, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The overall number of key employees were 1.
The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Leerink Partners, startups are often financed by Atlas Venture, Omega Funds, The Column Group. The meaningful sponsors for the fund in investment in the same round are Foresite Capital, Fidelity Management and Research Company, Cormorant Asset Management. In the next rounds fund is usually obtained by The Baupost Group, Omega Funds, North Bridge Venture Partners & Growth Equity.
Considering the real fund results, this Corporate Investor is 13 percentage points less often commits exit comparing to other organizations. Deals in the range of 50 - 100 millions dollars are the general things for fund. The higher amount of exits for fund were in 2018. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Leerink Partners performs on 31 percentage points more the average number of lead investments. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 17
- Lead investments
- 1
- Exits
- 12
- Rounds per year
- 0.59
- Follow on index
- 0.06
- Investments by industry
- Biotechnology (13)
- Health Care (13)
- Medical (7)
- Genetics (6)
- Therapeutics (5) Show 8 more
- Investments by region
-
- United States (16)
- Peak activity year
- 2018
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 1.00
- Avg. company exit year
- 16
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Fieldoo | 01 Mar 2012 | Internet, Mobile, Sports, Professional Networking, Soccer | Seed | 590K | Slovenia, Ljubljana Urban Commune, Ljubljana |
Odyssey Therapeutics | 05 Dec 2023 | Biotechnology, Health Care | Late Stage Venture | 101M | United States, Massachusetts, Cambridge |
Replimune Group | 08 Sep 2017 | Biotechnology, Health Care, Medical, Therapeutics | Early Stage Venture | 55M | United States, Massachusetts, Woburn |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.